The identification, treatment, and control of carbapenem-resistant Enterobacteriaceae (CRE) infections are a major challenge for health care institutions and diagnostic laboratories worldwide. Those producing plasmid-mediated OXA-48, KPC, NDM, or VIM-like carbapenemases (CPE) are most concerning,
No takes yet. Share an insight, caveat, or question.
Wareham et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: